The Fanconi Anemia Research Fund (FARF) is closely monitoring the updates regarding COVID-19, a respiratory illness caused by a new coronavirus, as well as potential implications on the FA community.
FARF has existed for more than 30 years, and in that time, few researchers can say they’ve dedicated their career to studying Fanconi anemia. Dr. Alan D’Andrea is one of those researchers.
FA is associated with bone marrow failure, cancer predisposition, and congenital abnormalities. What do we know about central nervous system abnormalities?
Read updates about FA cancer research shared at the 2019 FARF Scientific Symposium
An update on three FA clinical trials presented at the 2019 FARF Scientific Symposium
Aldehydes can cause DNA damage to hematopoietic stem cells, leading to bone marrow failure and cancer. Where are we with research into aldehydes in FA? Read this update from the 2019 Symposium.